Sinusitis and Facial Pain Disorders Anti-Depression Trial

Trial Profile

Sinusitis and Facial Pain Disorders Anti-Depression Trial

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Oct 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Facial pain; Major depressive disorder; Sinusitis
  • Focus Therapeutic Use
  • Acronyms SFPAT
  • Most Recent Events

    • 02 Aug 2012 Planned end date changed from 1 Jan 2018 to 1 Dec 2012 as reported by ClinicalTrials.gov record.
    • 02 Aug 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 11 Mar 2011 Actual patient number added 3 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top